Covid-19: Anti-viral drug at an affordable price?
Covid-19 - When the symptoms of infection increase, these drugs can be taken as part of treatment in an emergency situation. The covid vaccine can help reduce the severity of a viral infection and increase the likelihood of developing a covid infection.
The situation changed drastically when people with chronic diseases and those with co-morbidities became infected with the coronavirus. Therefore, studies are being carried out to prevent the spread of covid virus infection. In that sense, the antiviral drug is being introduced by Mankind Pharma at a very affordable price.
The capsule manufactured by Mankind under the brand name Monolife is called Molnupiravir. The price of a capsule is Rs. 35 is determined. An infected person has to take this medicine twice a day, for five days and the recommended dose is 800 mg. Hence, this pill is being manufactured at a dose of 200 mg, but to get the recommended dosage the infected person has to take 40 capsules.
RJ Juneja the founder of Mankind Pharma has told that the total treatment cost of this drug is Rs.1,400. Also, this antiviral drug is not for everyone. Medical guidelines are provided for who can take this anti-viral drug. 13 indian medication firms, including Torrent, Cipla, sun Pharma, Dr. Reddy's Labs, Mylan, and Hetero, have come forward to manufacture this antiviral pill. Multiple companies are already implicated in the production of this antiviral drug and the drug will be cast in a few weeks by three companies namely Cipla, sun Pharma, and Dr. Reddy's Laboratory.
click and follow Indiaherald WhatsApp channel